Disagree
Home Substances
Tesofensine

Tesofensine

A-Z
Search for:
Substance Overview and History

Tesofensine is a medication, for tackling obesity that acts by inhibiting the reuptake of three neurotransmitters; dopamine, serotonin and norepinephrine in the brain. Is is also effectively reduces food intake and helps people lose weight consistently in both animals and humans. In addition to curbing hunger pangs tesofensine also boosts energy expenditure in those on high fat diets. Its main target is the GABAergic neurons which can be found in the hypothalamus, this potentially lead to changes, in eating habits and provide perspectives on treating obesity.

References:

Perez, C.I., Luis-Islas, J., Lopez, A., Diaz, X., Molina, O., Arroyo, B., Moreno, M.G., Gil Lievana, E., Fonseca, E., Castañeda-Hernández, G. and Gutierrez, R., 2024. Tesofensine, a novel antiobesity drug, silences GABAergic hypothalamic neurons. PLoS One

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For more details consult with your doctor or healthcare professional.

FAQ
What is Tesofensine primarily used for?
Tesofensine is used as an anti obesity drug to reduce appetite and promote weight loss.
References:

Perez, C.I., Luis-Islas, J., Lopez, A., Diaz, X., Molina, O., Arroyo, B., Moreno, M.G., Gil Lievana, E., Fonseca, E., Castañeda-Hernández, G. and Gutierrez, R., 2024. Tesofensine, a novel antiobesity drug, silences GABAergic hypothalamic neurons. PLoS One

How does Tesofensine work?
It acts as a triple monoamine re uptake inhibitor which is affecting dopamine, serotonin, and norepinephrine levels
References:

Perez, C.I., Luis-Islas, J., Lopez, A., Diaz, X., Molina, O., Arroyo, B., Moreno, M.G., Gil Lievana, E., Fonseca, E., Castañeda-Hernández, G. and Gutierrez, R., 2024. Tesofensine, a novel antiobesity drug, silences GABAergic hypothalamic neurons. PLoS One

Does Tesofensine only suppress appetite?
No, it not only reduces appetite but also boosts energy expenditure.
References:

Perez, C.I., Luis-Islas, J., Lopez, A., Diaz, X., Molina, O., Arroyo, B., Moreno, M.G., Gil Lievana, E., Fonseca, E., Castañeda-Hernández, G. and Gutierrez, R., 2024. Tesofensine, a novel antiobesity drug, silences GABAergic hypothalamic neurons. PLoS One